Vivos Therapeutics (VVOS) Operating Leases (2021 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Operating Leases of $3.7 million for Q1 2026, up 291.95% year-over-year from $932000.0 in Q1 2025, and down 4.87% quarter-over-quarter from $3.8 million in Q4 2025.
Vivos Therapeutics (VVOS) Operating Leases (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Operating Leases for 6 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases rose 291.95% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 291.95% YoY), while the FY2025 annual figure was $3.8 million, up 271.01% from the prior year.
- Operating Leases slipped to $3.7 million in Q1 2026 per VVOS's latest filing, from $3.8 million in the prior quarter.
- Across five years, Operating Leases topped out at $3.8 million in Q4 2025 and bottomed at $932000.0 in Q1 2025.
- Historically, Operating Leases has averaged $2.1 million across 5 years, with a median of $1.9 million in 2023.
- Annual changes were most pronounced in 2025 — Operating Leases slumped 50.48% — and 2026, when it jumped 291.95%.
- Vivos Therapeutics' Operating Leases stood at $2.0 million in 2022, then dropped by 23.72% to $1.5 million in 2023, then plunged by 31.95% to $1.0 million in 2024, then jumped by 271.01% to $3.8 million in 2025, then retreated by 4.87% to $3.7 million in 2026.
- Business Quant data shows VVOS's Operating Leases at $3.7 million in Q1 2026, $3.8 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 932,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.99 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 1.85 Mn |
| Dec 31, 2021 | 641,000.00 |